Department of Orthopaedics, The Second Hospital of Shanxi Medical University; Shanxi Key Lab of Bone and Soft Tissue Injury Repair, Taiyuan, China.
The Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, China.
Orthop Surg. 2020 Apr;12(2):378-387. doi: 10.1111/os.12662. Epub 2020 Mar 16.
To describe the outcomes of autografts and synthetics in anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) reconstruction with respect to instrumented laxity measurements, patient-reported outcome scores, complications, and graft failure risk. We searched PubMed, Cochrane Library, and EMBASE for published randomized controlled trials (RCT) and case controlled trials (CCTs) to compare the outcomes of the autografts versus synthetics after cruciate ligament reconstruction. Data analyses were performed using Cochrane Collaboration RevMan 5.0. Nine studies were identified from the literature review. Of these studies, three studies compared the results of bone-patellar tendon-bone (BPTB) and ligament augmentation and reconstruction system (LARS), while six studies compared the results of four-strand hamstring tendon graft (4SHG) and LARS. The comparative study showed no difference in Lysholm score and failure risk between autografts and synthetics. The combined results of the meta-analysis indicated that there was a significantly lower rate of side-to-side difference > 3 mm (Odds Ratio [OR] 2.46, 95% confidence intervals [CI] 1.44-4.22, P = 0.001), overall IKDC (OR 0.40, 95% CI 0.19-0.83, P = 0.01), complications (OR 2.54, 95% CI 1.26-5.14, P = 0.009), and Tegner score (OR -0.31, 95% CI -0.52-0.10, P = 0.004) in the synthetics group than in the autografts group. This systematic review comparing long-term outcomes after cruciate ligament reconstruction with either autograft or synthetics suggests no significant differences in failure risk. Autografts were inferior to synthetics with respect to restoring knee joint stability and patient-reported outcome scores, and were also associated with more postoperative complications.
描述前交叉韧带(ACL)和后交叉韧带(PCL)重建中自体移植物和合成物的结果,包括仪器松弛测量、患者报告的结果评分、并发症和移植物失败风险。我们在 PubMed、Cochrane 图书馆和 EMBASE 中搜索了已发表的随机对照试验(RCT)和病例对照试验(CCT),以比较 ACL 重建后自体移植物与合成物的结果。使用 Cochrane 协作 RevMan 5.0 进行数据分析。从文献综述中确定了 9 项研究。其中 3 项研究比较了骨-髌腱-骨(BPTB)和韧带增强和重建系统(LARS)的结果,6 项研究比较了四股腘绳肌腱移植物(4SHG)和 LARS 的结果。比较研究显示,自体移植物和合成物在 Lysholm 评分和失败风险方面没有差异。荟萃分析的综合结果表明,侧侧差值>3 毫米的发生率显著降低(优势比[OR]2.46,95%置信区间[CI]1.44-4.22,P=0.001),整体 IKDC(OR 0.40,95% CI 0.19-0.83,P=0.01),并发症(OR 2.54,95% CI 1.26-5.14,P=0.009)和 Tegner 评分(OR-0.31,95% CI-0.52-0.10,P=0.004)在合成物组中低于自体移植物组。本系统评价比较了 ACL 重建后使用自体移植物或合成物的长期结果,结果表明失败风险无显著差异。自体移植物在恢复膝关节稳定性和患者报告的结果评分方面劣于合成物,并且还与更多的术后并发症相关。